NO902833L - Oksidativ denaturering av protein analytter. - Google Patents

Oksidativ denaturering av protein analytter.

Info

Publication number
NO902833L
NO902833L NO90902833A NO902833A NO902833L NO 902833 L NO902833 L NO 902833L NO 90902833 A NO90902833 A NO 90902833A NO 902833 A NO902833 A NO 902833A NO 902833 L NO902833 L NO 902833L
Authority
NO
Norway
Prior art keywords
protein
analysts
denaturing
oxidative
oxidizing agent
Prior art date
Application number
NO90902833A
Other languages
English (en)
Norwegian (no)
Other versions
NO902833D0 (no
Inventor
James Elting
Heinz Koelbl
Original Assignee
Molecular Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Molecular Diagnostics Inc filed Critical Molecular Diagnostics Inc
Publication of NO902833D0 publication Critical patent/NO902833D0/no
Publication of NO902833L publication Critical patent/NO902833L/no

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57565—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen [CEA]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5306—Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
NO90902833A 1989-07-10 1990-06-26 Oksidativ denaturering av protein analytter. NO902833L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/377,680 US5061790A (en) 1989-07-10 1989-07-10 Oxidative denaturation of protein analytes

Publications (2)

Publication Number Publication Date
NO902833D0 NO902833D0 (no) 1990-06-26
NO902833L true NO902833L (no) 1991-01-11

Family

ID=23490110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO90902833A NO902833L (no) 1989-07-10 1990-06-26 Oksidativ denaturering av protein analytter.

Country Status (18)

Country Link
US (1) US5061790A (ja)
EP (1) EP0407813B1 (ja)
JP (1) JP2915970B2 (ja)
KR (1) KR910003380A (ja)
AT (1) ATE147167T1 (ja)
AU (1) AU633115B2 (ja)
CA (1) CA2019671C (ja)
DE (1) DE69029540T2 (ja)
DK (1) DK0407813T3 (ja)
ES (1) ES2095847T3 (ja)
FI (1) FI903464A7 (ja)
GR (1) GR3022906T3 (ja)
IE (1) IE902493A1 (ja)
IL (1) IL94993A (ja)
NO (1) NO902833L (ja)
NZ (1) NZ234396A (ja)
PT (1) PT94633B (ja)
ZA (1) ZA905360B (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2740223B1 (fr) * 1995-10-19 1997-11-14 Commissariat Energie Atomique Procede de determination d'auto-anticorps revelateurs de complications pathologiques ; dans le serum sanguin, en particulier de diabetiques
US20030202980A1 (en) * 1995-12-29 2003-10-30 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US7879977B2 (en) 1998-01-31 2011-02-01 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
CA2319437C (en) 1998-01-31 2009-06-16 University Of Arkansas Methods and reagents for decreasing allergic reactions
GB9827845D0 (en) * 1998-12-17 1999-02-10 Scolab S A Immunoassay or proteins
US20050063994A1 (en) * 2000-04-06 2005-03-24 Caplan Michael J. Methods and reagents for decreasing clinical reaction to allergy
US8153414B2 (en) * 2000-04-06 2012-04-10 Allertein Therapeutics, Llc Microbial delivery system
US8246945B2 (en) * 2000-04-06 2012-08-21 University Of Arkansas Methods and reagents for decreasing clinical reaction to allergy
WO2003002908A1 (en) * 2000-06-26 2003-01-09 Reveo, Inc. Backlight for a liquid crystal display having high light-recycling efficiency
DE10054055A1 (de) * 2000-10-31 2002-05-23 Nmi Univ Tuebingen Verfahren zur Analyse von Proteinen
US7460960B2 (en) * 2002-05-10 2008-12-02 Epitome Biosystems, Inc. Proteome epitope tags and methods of use thereof in protein modification analysis
US7618788B2 (en) * 2002-05-10 2009-11-17 Millipore Corporation Proteome epitope tags and methods of use thereof in protein modification analysis
US7892751B2 (en) * 2003-06-09 2011-02-22 Redox-Reactive Reagents Llc Method of detecting or diagnosing of a neurodegenerative disease or condition
US9557325B2 (en) * 2003-06-09 2017-01-31 Redox-Reactive Reagents Llc Method of altering the binding specificity of proteins by oxidation-reduction reactions
ATE518886T1 (de) * 2003-06-09 2011-08-15 Redox Reactive Reagents L L C Verfahren zur änderung der bindungsspezifität von plasmaproteinen durch oxidations- reduktionsreaktionen
US7855057B2 (en) * 2006-03-23 2010-12-21 Millipore Corporation Protein splice variant/isoform discrimination and quantitative measurements thereof
CN101627306B (zh) * 2007-03-08 2014-02-05 霍夫曼-拉罗奇有限公司 Slim-1在心力衰竭评估中的用途
KR101322247B1 (ko) * 2007-09-06 2013-10-25 삼성전자주식회사 진공청소기용 흡입브러시 및 그 높이조절방법
US20090280474A1 (en) * 2008-05-08 2009-11-12 Abbott Laboratories Method for detecting a virus
US20130189707A1 (en) * 2010-01-26 2013-07-25 Svetlana Alexandrovna Sergeeva Method of determination of autoantibody level by means of enzyme immunoassay
WO2013116260A1 (en) * 2012-02-02 2013-08-08 Perfinity Biosciences, Inc. Selector based recognition and quantification system and method for multiple analytes in a single analysis

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2448530C3 (de) * 1974-10-11 1980-03-27 Behringwerke Ag, 3550 Marburg Verfahren zum Herstellen von Derivaten des Diphtherietoxins und diese enthaltende Mittel
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes
US4683136A (en) * 1985-03-06 1987-07-28 Scripps Clinic And Research Foundation Proteinaceous antigens with conformation-independent and conformation-dependent determinants
US4713366A (en) * 1985-12-04 1987-12-15 The Ohio State University Research Foundation Antigenic modification of polypeptides

Also Published As

Publication number Publication date
ES2095847T3 (es) 1997-03-01
AU5872790A (en) 1991-01-10
DK0407813T3 (da) 1997-06-16
IE902493A1 (en) 1991-02-13
GR3022906T3 (en) 1997-06-30
AU633115B2 (en) 1993-01-21
FI903464A0 (fi) 1990-07-09
EP0407813B1 (en) 1997-01-02
DE69029540T2 (de) 1997-05-07
ATE147167T1 (de) 1997-01-15
KR910003380A (ko) 1991-02-27
EP0407813A2 (en) 1991-01-16
DE69029540D1 (de) 1997-02-13
US5061790A (en) 1991-10-29
JP2915970B2 (ja) 1999-07-05
PT94633A (pt) 1991-03-20
CA2019671C (en) 2002-08-13
PT94633B (pt) 1997-04-30
IL94993A (en) 1994-05-30
NZ234396A (en) 1992-02-25
IL94993A0 (en) 1991-06-10
CA2019671A1 (en) 1991-01-10
ZA905360B (en) 1991-04-24
JPH0368868A (ja) 1991-03-25
FI903464A7 (fi) 1991-01-11
EP0407813A3 (en) 1992-11-25
NO902833D0 (no) 1990-06-26

Similar Documents

Publication Publication Date Title
NO902833L (no) Oksidativ denaturering av protein analytter.
ES2059719T3 (es) Mejoras relativas a anticuerpos.
DE59209129D1 (de) Verwendung von Antikörper enthaltenden Präparationen zur Immunsuppression
DE3852116D1 (de) Herstellung von Proteinen in aktiver Form.
ES2129487T3 (es) Peptidos sinteticos, anticuerpos dirigidos contra ellos y su utilizacion.
DE69334183D1 (de) Von cyclodextrinen stabilisierter radiopharmazeutischer reagenzsatz
DE3478395D1 (de) Caries-preventive composition
FI93842B (fi) Menetelmä proteiinien renaturoimiseksi
PT93178A (pt) Agente proteico anticanceroso
MX9207459A (es) Anticuerpos humanizados reactivos con gpiib/iiia.
KR927003623A (ko) 변성단백질의 활성회복 방법
DE59310280D1 (de) Verfahren zur Herstellung von Konjugaten aus einem spezifischen Bindungspartner und einem kohlenhydrathaltigen Protein
DE3877015D1 (de) Antikoerper enthaltende stabilisierte waesserige zusammensetzung.
ATE110774T1 (de) Gegen menschliches fibrinopepid a spezifische monoklonale antikörper.
DK447784A (da) Immuninterferon
FI840949L (fi) Toxiner och antikroppar av mikro- organismen c.difficile.
DE69112904D1 (de) Immunologische Vermehrung des somatogenischen Effekts von Somatotropin mit einem Antikörper.